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1. Introduction 
The mechanism whereby occupancy of cell surface 
receptors for hormones and neurotransmitters is 
coupled to intracellular events is of much interest. 
Because occupancy by agonists of many such recep- 
tors activates adenylate cyclase, events involved in 
receptor-cyclase coupling have been emphasized. 
In characterizing components of the cyclase system 
much work has involved wild-type S49 lymphoma 
cells and variant S49 clones having lesions in the path- 
way for generation of adenosine 3’:.5’-monophosphate 
(CAMP) [ 1,2]. 0 ne of these S49 variants was termed 
UNC because it possessed adenylate cyclase and hor- 
mone receptors for /3-adrenergic amines and prosta- 
glandin El (PGE,), but occupation of these receptors 
was unable to stimulate CAMP generation in these 
cells [3]. Studies in S49 and other cells indicate that 
GTP is an obligatory co-factor for hormonal activa- 
tion of adenylate cyclase and that hydrolysis of GTP 
may ‘turn off’ activated adenylate cyclase [2,4,5]. In 
addition, a non-hormonal activator of adenylate 
cyclase, cholera toxin (choleragen, the enterotoxin 
derived from the bacterium V&z’o cholerae), enhances 
CAMP synthesis, apparently by inhibiting GTP hydro- 
lysis [6,7]. Here, we show that as a possible conse- 
quence of this inhibition of GTP hydrolysis, cholera 
toxin treatment of intact wild-type S49 cells enhances 
coupling of hormone receptors to adenylate cyclase. 
Moreover, we find that incubation of the UNC variant 
S49 cells with cholera toxin allows expression of 
catecholamine and PGEl-stimulated CAMP genera- 
tion. These results suggest hat cholera toxin may be 
a useful tool for enhancing hormone-stimulated 
CAMP generation even in cells in which receptors are 
functionally uncoupled from adenylate cyclase. 
Elsevier/North-Holland Biomedical Press 
2. Experimental 
S49 cells were grown in suspension culture in 
Dulbecco’s modified Eagle’s medium (DME medium) 
supplemented with 10% heat-inactivated horse serum 
and 3 g glucose/l (final cont.). Cells growing loga- 
rithmically (I-2.5 X lo6 cells/ml) were centrifuged 
and then resuspended in either DME medium or 
medium in which 20 mM Na-Hepes [4(-2-hydroxy- 
ethyl)-I-piperazine-ethanesulfonate] replaced NaHC03 
and 0.1% bovine serum albumin replaced the horse 
serum. Cells were then incubated in the presence or 
absence of 100 ng cholera toxin/ml (Schwarz Mann) 
for 1 h at 37°C. At the completion of this incubation, 
aliquots of cells were used to measure CAMP accumu- 
lation or [3H] dihydroalprenolol binding. For CAMP 
accumulation, cells were added to tubes containing 
freshly prepared 1 mM ascorbic acid (final cont.) and 
variable concentrations of (--)isoproterenol (kindly 
donated by Sterling-Winthrop Research Labs). Tubes 
were incubated for 10 min at 37°C and the incuba- 
tions were terminated by centrifuging samples in a 
Beckman microfuge for 20-30 s, immediate removal 
of the extracellular medium and addition of 50 mM 
sodium acetate (pH 4.0) and 0.2 mM isobutylmethyl- 
xanthine. The resuspended cells were immediately 
boiled for 23 min and CAMP was determined in the 
resultant solution using a competitive binding protein 
assay method [IO]. [ 3H] Dihydroalprenolol (New 
England Nuclear, 48.6 Ci/mmol) binding was deter- 
mined in samples incubated for 5 min at 37°C as in 
[6, lo]. Non-specific binding, i.e., [ 3H] dihydroalpre- 
nolo1 bound in the presence of 0.3 PM (-)alprenolol, 
was subtracted from bound radioactivity to determine 
specific binding. 
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3. Results 
3.1. Effects of cholera toxin pretreatment of beta- 
adrenergic receptors and cAMPacc~m~~atio~ of
wild-type S49 cells 
Wild-type S49 cells grow in suspension culture and 
generate cAMP in response to /3-adrenergic atechol- 
amines, PGEr, and cholera toxin; membranes pre- 
pared from these cells also produce CAMP in response 
to Mn2’, NaF, and non-hydrolyzable GTP derivatives 
(such as Gpp(NH)p) [ 1,2,8,9]. Radioligand binding 
assays have been used to show that these cells have 
receptors for @-adrenergic catecholamines and PGEr 
[e-12]. When intact wild-type S49 cells were incu- 
bated with cholera toxin prior to treatment with the 
/3-adrenergic agonist isoproterenol, the cells had 
enhanced stimulation of cellular CAMP accumulation 
(fig.1, top); this result is similar to data observed in a 
variety of cell types [ 14-181. The primary effect in 
S49 cells was an enhanced maximal response to iso- 
protercnol. In addition, there was a 2-4-fold increase 
in potency of the /3 agonist after cholera toxin treat- 
ment. Cholera toxin also enhanced maximal responses 
of wild-type S49 cells to PGEl several-fold (not 
shown). 
The enhanced potency and maximal response to 
isoproterenoi after cholera toxin treatment was not 
attributable to an alteration in /3-adrenergic receptors 
of intact wild-type S49 cells (fig.1, bottom). When 
fi-adrenergic receptors were characterized in intact 
cells following cholera toxin treatment, we found 
that the treatment altered neither the no. [3H]dihydro- 
alprenolol binding sites/cell (15.50) nor the affinity 
of these sites for the radioligand itself (0.65 PM) or 
for isoproterenol(m1.6 FM) (fig.1, bottom). Similar 
results were obtained using plasma membranes isolated 
from toxin-treated wild-type S49 cells [8,9]. Thus, 
the enhanced response to isoproterenol produced by 
cholera toxin derives from an event distal to the 
receptor binding sites for the catecholamine. More- 
over, addition of the toxin increases even further the 
prominent discrepancy between the low concentra- 
tions of isoproterenol required for stimulation of 
CAMP accumulation and the much higher concentra- 
tions required to compete for radioligand binding 
sites in S49 cells [ 11 ,121. 
3.2. Effect of cholera toxin pretreatment on CAMP 
accumulation in UNC S49 cells 
The S49 variant cells called UNC are characterized 
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Fig.1. Effect of cholera toxin on the stimulation of CAMP 
accumu~tion by isoproterenoi (top) and on the binding of 
[3H]dihydroalprenolo1 (bottom) of wild-type S49 cells. Cells 
were incubated in the presence (0) or absence (@) of 100 ng 
cholera toxin/ml for 1 h and then CAMP accumulation and 
[ 3H]dihydroalprenolol binding were determined as described. 
(top) Data shown are the mean + SEM of values (duplicate 
determinations} from 3 separate CAMP accumulation studies. 
(bottom, inset) A Scatchard plot of binding data in which 
variable concentrations of [3H]dihydroalprenolo1 were incu- 
bated with cells. (bottom) The larger part illustrates mean 
data derived from 2 -3 separate experiments in which 334 nM 
f3H]dihydroalprenoloI was incubated with ceils in the pres- 
ence of varying concentrations of (-)-isoproterenol and 1 mM 
ascorbic acid. The experiments shown were performed in the 
absence of a phosp~iodiesterase inhibitor. Addition of an 
inhibitor such as Ro 20-1724 produces a 223-fold increase in 
CAMP accumulation in either the absence or presence of 
cholera toxin. 
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Table 1 
Effects of cholera toxin on isoproterenol- and 
PCE, -stimulated cyclic AMP accumulation in UNC S49 cells 
Expt Basal IS0 PGE, CT CT+ CT+ 
IS0 PGE, 
1 235 202 224 1569 2478 3044 
2 9 7 5 380 734 854 
3 129 154 154 1041 2076 2648 
__~. 
UNC S49 cells were incubated in the absence or presence of 
cholera toxin (CT) (100 ng/ml) for 2 h. Aliquots of cells were 
then incubated with 1 ).IM isoproterenol (ISO), 1 PM prosta- 
glandin E, (PGE,), or neither for an additional 6 min prior to 
termination of incubation and assay of cyclic AMP as in fig.1. 
The data shown are the mean values of duplicate cyclic AMP 
(pmol/107 cells) determinations in separate studies 
by the presence of hormone receptors that are unable 
to generate CAMP in response to either PGEr or 
/3-adrenergic agonists ([3] and table 1). /I-Adrenergic 
receptors in intact UNC cells are similar in number 
and affinity to receptors in wild-type S49 cells [ 121. 
In spite of their unresponsiveness under basal condi- 
tions, UNC cells that were incubated with cholera 
toxin demonstrated PGEr- and isoproterenol-stimu- 
lated CAMP accumulation (fig.2, table 1). Toxin- 
treated UNC cells had a similar dose-response pattern 
(EC5e value of -5 nM) for isoproterenol-stimulated 
CAMP accumulation as did wild-type S49 (fig.2) and 
also had no change in the ability of isoproterenol to 
compete for [3H]dihydroalprenolol binding sites. As 
table 1 and fig.2 show, in a series of experiments we 
observed much variability between absolute levels of 
CAMP determined under basal and stimulated condi- 
tions. Nevertheless, cholera toxin enhances hormonal 
response by roughly similar percentages (SO-loo% 
for isoproterenol and 90-l 50% for PGEr) in all the 
studies. The variability in results between these exper- 
iments makes it difficult for us to calculate the extent 
to which recoupling of UNC with cholera toxin yields 
hormonal responses that are quantitatively similar to 
those seen with wild-type cells; on a percentage basis, 
the enhancement of response in wild-type cells appears 
to be -3-fold greater than for UNC cells. 
4. Discussion 
These results demonstrate that fl-adrenergic and 
PGEr receptors are not permanently uncoupled from 
adenylate cyclase in the UNC variants. Based on 
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Fig.2. Effect of isoproterenol and cholera toxin on cyclic 
AMP levels in UNC S49 cells. Logarithmically growing UNC 
cells were handled essentially as in fig.1 with the exception 
that the phosphodiesterase inhibitor Ro 20-1724 at a final 
concentration of 0.1 mM was added to cells and cells were 
incubated in the presence of 100 ng cholera toxin/ml. Samples 
were incubated with toxin for 2 h and then varying concen- 
trations of (-)-isoproterenol were added for an additional 
6 min prior to termination of incubation and assay as 
described. The data shown are mean k SEM for triplicate 
determinations at each concentration except for data obtained 
in the absence of isoproterenol in which 7 determinations 
were performed. 
results in several systems, including S49 cells, cholera 
toxin appears to act by catalyzing the reversible ADP 
ribosylation of a nucleotide (probably GTP) binding 
component which is involved in hormone-stimulated 
adenylate cyclase activity [20,22]. In turkey erythro- 
cyte membranes, this covalent modification of the 
GTP binding unit correlates with inhibition of a cate- 
cholamine-stimulated GTPase activity [20,21]. In 
plasma membranes from UNC cells, isoproterenol was 
able to stimulate a small amount of adenylate cyclase 
activity in the presence of the poorly hydrolyzed 
GTP derivative guanylylimidodiphosphate (Gpp(NH)p), 
but not in the presence of GTP [3]. The enhanced 
hormonal response that we find in intact UNC cells 
in response to cholera toxin may thus result from 
inhibition of GTP hydrolysis by the toxin in these 
cells. We conclude that the findings on the mechanism 
of toxin in isolated membranes are likely to be opera- 
tive in intact cells [6]. 
61 
Volume 128, number 1 I:EBS LETTERS June 1981 
UNC membranes contain the same cholera toxin 
[ 32P]NAD labelled substrates as do wild-type mem- 
branes [22] and cholera toxin-labelled substrates in 
UNC have more acidic isoelectric points than do sub- 
strates from wild-type S49 cells [23]. Our results 
suggest hat these altered cholera toxin substrates are 
still able to permit the ‘recoupling’ of receptors and 
adenylate cyclase. Nevertheless, considering the 
apparent quantitative differences that we observed in 
cholera toxin-promoted enhancement of hormonal 
responses in wild-type and UNC S49 cells, the more 
acidic toxin substrates may be functionally defective. 
Alternatively, we cannot exclude the possibility that 
cholera toxin may alter proteins in addition to the 
nucleotide binding unit [24]. 
The wider implication of these results involves 
the potential utility of cholera toxin to enhance 
receptor-cyclase coupling. Although increased hor- 
monal response in the presence of cholera toxin has 
been noted [ 13-17,251, our finding that the toxin 
can confer hormonal response on cells containing 
receptors but otherwise lacking response suggests 
that the toxin may be useful in other systems as well 
in helping to unmask ‘latent’ or non-functional hor- 
mone receptors [25,26]. 
The prominent diarrhea associated with the disease 
cholera is produced by the increased CAMP levels in 
intestinal epithelial cells mediating fluid and electro- 
lyte transport [26]. Although cholera toxin itself is 
able to stimulate CAMP levels, our findings raise the 
possibility that the toxin sensitizes the adenylate 
cyclase of those cells to local and circulating agonists 
for which the cells bear receptors, but which are 
functionally uncoupled in the absence of the toxin. 
Because we can only speculate about the possible 
existence of such receptors, further studies will be 
required to show whether this postulated effect of 
cholera toxin occurs in intestinal and other cells. It 
will also be of interest to determine whether recou- 
pling of receptors occurs with other bacterial toxins 
that are thought to act in a manner similar to cholera 
toxin (e.g., the heat-labile toxin of Eschetichia coli [28]). 
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